Aclarion, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACON research report →
Companywww.aclarion.com
Aclarion, Inc. , a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software.
- CEO
- Brent Ness
- IPO
- 2022
- Employees
- 5
- HQ
- Broomfield, CA, US
Price Chart
Valuation
- Market Cap
- $1.70M
- P/E
- -0.84
- P/S
- 21.84
- P/B
- 0.35
- EV/EBITDA
- 2.18
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -58.86%
- Op Margin
- -10975.10%
- Net Margin
- -10336.12%
- ROE
- -0.00%
- ROIC
- -43.49%
Growth & Income
- Revenue
- $75.73K · 65.62%
- Net Income
- $-7,233,629 · -3.44%
- EPS
- $-13.61 · 99.82%
- Op Income
- $-7,052,391
- FCF YoY
- -28.46%
Performance & Tape
- 52W High
- $12.03
- 52W Low
- $2.34
- 50D MA
- $3.30
- 200D MA
- $5.36
- Beta
- 1.19
- Avg Volume
- 93.05K
Get TickerSpark's AI analysis on ACON
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 12, 26 | Breidbart Scott | buy | 5,664 |
| May 11, 26 | Neal David K | buy | 2,500 |
| May 11, 26 | Ness Brent | buy | 6,289 |
| May 6, 26 | Wesemann William | buy | 1,562 |
| Nov 26, 25 | Ness Brent | buy | 10 |
| Sep 2, 25 | Gould Gregory A | other | 17,000 |
| Sep 2, 25 | Gould Gregory A | other | 0 |
| Mar 28, 23 | Thramann Jeffrey John | other | 1 |
| Feb 16, 23 | Thramann Jeffrey John | buy | 1 |
| Dec 29, 22 | Ness Brent | buy | 7,711 |
Our ACON Coverage
We haven't published any research on ACON yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ACON Report →